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Intracystic Papillary Carcinoma in a Man with 
Gynecomastia 
Joshua B. Johnson, B.Ch.E., and Tim H. Emory, M.D. 
Male breast cancer is a rare disease in the male breast whereas gynecomastia is quite common. An 
elevation of the estrogen-to-androgen ratio increases the risk of both of these diseases. However, 
a connection between gynecomastia and subsequent breast cancer development is controversial 
and unclear. Imaging studies including mammography and ultrasound provide valuable informa-
tion in leading to a correct diagnosis. Traditionally, intracystic papillary carcinoma, also known as 
encapsulated papillary carcinoma, has been considered a form of ductal carcinoma in situ. Recent 
immunohistochemical studies, demonstrating an absence of myothelium, in many cases would be 
more compatible with the diagnosis of invasive malignancy. However, intracystic papillary carci-
noma holds a favorable prognosis with local therapy alone. We report a case of intracystic papil-
lary carcinoma in a male patient with long-standing gynecomastia diagnosed eight years prior by 
mammography. The patient presented with a breast lump on both occasions. Current work-up 
consisted of both mammography and ultrasound. Ultrasound provided key information reveal-
ing a complex mass requiring further evaluation. Ultrasound-guided core needle biopsy revealed 
intracystic papillary carcinoma with confirmation upon surgical excision. 
Male breast cancer is a rare disease, estimated to 
comprise less than 0.3% of all male cancer cases and 
approximately 1% of all breast cancer cases in 2008 [1]. 
The papillary variant of breast cancer represents 1 to 
2% of cases in women but is relatively more common 
in males, representing 3 to 5% of cases [2]. Intracystic 
papillary carcinoma is also referred to as encapsulated 
papillary carcinoma based on recent immunohis-
tochemical studies [3,4]. The differential diagnosis for a 
male breast lump includes both gynecomastia and male 
breast cancer. The prevalence of gynecomastia in the 
general population shows a bimodal peak in neonates 
and again in the elderly and is much more common 
than one would expect, up to 60% in men over 50 [5]. 
Introduction
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Figure 1A. 70-year-old man with intracystic papillary carci-
noma. Eight years prior to presentation, CC mammogram 
revealed bilateral gynecomastia, with right greater than left.
Case Report
A 70-year-old man was referred to our Breast Center 
from his primary care provider with the chief complaint 
of a left breast lump. The patient was seen eight years 
prior to the current presentation with a lump in his 
opposite breast. Mammography performed eight years 
prior to the current presentation revealed bilateral gyne-
comastia, with right greater than left (Fig. 1). 
On current evaluation, the patient presented with 
the history of a left breast lump for more than one 
month with no associated pain or nipple discharge. 
RIGHT    LEFT
The risk for both gynecomastia and male breast cancer is 
increased given a prolonged elevation of the estrogen-to-
androgen ratio. However, the link between gynecomastia 
and subsequent development of breast cancer remains 
unclear. We report the case of a 70-year-old male with 
gynecomastia previously diagnosed by mammography 
presenting eight years later with a breast lump. Mam-
mography and ultrasound findings led to ultrasound-
guided core-needle biopsy and subsequent surgical 
excision, which confirmed the diagnosis of intracystic 
papillary carcinoma. 
He had no family history of breast cancer. On physi-
cal exam, there was a 2 cm, visible and palpable lump 
beneath the left areola of the left breast with no nipple 
retraction or discharge. Axillary lymph nodes were not 
palpable and exam of the right breast was unremarkable.
Digital mammography demonstrated a well-
circumscribed, rounded, 2.5 cm hyperdense mass 
underlying the left nipple, and mild gynecomastia (Fig. 
2). Ultrasound of the left breast lump demonstrated a 
well-circumscribed, mostly cystic, complex mass with a 
solid nodular component along one wall, measuring 2.4 
by 1.4 by 2.4 cm (Fig. 3). On Doppler, blood flow was 
present within the nodular component (Fig. 4). 
Ultrasound-guided core-needle biopsy of the left 
breast lesion revealed grade II papillary carcinoma. Myo-
epithelial cell marker stains of smooth muscle myosin, 
p63, calponin and cytokeratin 5/6 were negative, sup-
porting the diagnosis. The specimen was estrogen recep-
tor positive at 100% and progesterone receptor positive 
at 80%. Her2/Neu FISH testing revealed no evidence of 
amplification of the HER2 gene. The patient underwent 
left simple mastectomy with left axillary sentinel lymph 
node biopsy. The left axillary sentinel lymph node 
removed was negative for metastatic disease. Left breast 
mastectomy confirmed the diagnosis of grade II non-
invasive intracystic papillary carcinoma.
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RIGHT    LEFT
Figure 1B. 70-year-old man with intracystic papillary carci-
noma. Eight years prior to presentation, MLO mammogram 
revealed bilateral gynecomastia, with right greater than left.
Figure 2A. 70-year-old man with intracystic papillary 
carcinoma. At presentation, CC mammogram revealed a 
well-circumscribed hyperdense mass under the nipple of 
the left breast. 
RIGHT    LEFT
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Almost all diagnostic imaging of the male breast is 
for evaluation of a palpable lump, breast enlargement, or 
tenderness [6], which are nonspecific for gynecomastia 
or male breast cancer. Imaging studies contribute helpful 
information in ultimately making a correct diagnosis 
with mammography generally performed first, with 
reported 90% sensitivity and specificity in discriminat-
ing between benign and malignant disease [7]. The 
glandular development of the breast in gynecomastia 
is readily apparent on mammography, extending back 
from the nipple often described as a triangular or flame-
shaped density [8]. Ultrasound of gynecomastia reveals 
various amounts of hypoechoic subareolar ducts with 
varying amounts of periductal fibrous tissue, depending 
on the phase the gynecomastia is in [9]. With intracystic 
papillary carcinoma, mammography reveals a circum-
scribed mass, representing the cyst and associated solid 
malignant component [10]. A circumscribed mass on 
mammography in a male is suspicious and should not 
be classified BIRADS 3, probably benign, as there is a 
decreased incidence of benign cysts, fibroadenomas, or 
Discussion
Figure 2B. 70-year-old man with intracystic papillary 
carcinoma. At presentation, MLO mammogram revealed a 
well-circumscribed hyperdense mass under the nipple of 
the left breast. 
RIGHT    LEFT
other benign round masses in the male. Given a circum-
scribed mass, which is not consistent with gynecomastia, 
ultrasound is warranted [9]. Ultrasound of intracystic 
papillary carcinoma demonstrates a complex solid and 
cystic mass; Doppler may demonstrate intratumoral 
blood flow or large feeding vessels [10]. In regards to 
biopsy, ultrasound guided core-needle biopsy has shown 
utility in successfully diagnosing intracystic papillary 
carcinoma and is preferred over fine-needle aspiration 
[5,11]. It also proves to be easier and more reliable given 
the small size of male breasts.
Gynecomastia is associated with conditions with 
low testosterone levels, high testosterone conversion 
to estrogen, high estrogen levels, or high sex hormone 
binding globulin levels [5]. Some examples include 
certain drugs, exogenous hormones, certain tumors, and 
genetic factors. Male breast cancer risk is increased with 
androgen deficiency, a family history of breast cancer, 
and certain gene mutations such as BRCA1 and BRCA2 
[5]. Those with Klinefelter syndrome, a condition 
with high estrogen levels, have increased risk for both 
gynecomastia and male breast cancer. Yet, a connec-
tion between gynecomastia and subsequent male breast 
cancer is controversial.
The prevalence of gynecomastia demonstrates a wide 
range depending on patient age, with the prevalence for 
neonates at 65-90%, adolescents at 40%, ages 16-20 at 
19%, ages 25-45 at 33-41%, and age over 50 at 55-60% 
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Figure 3A. 70-year-old man with intracystic papillary car-
cinoma. At presentation, long-axis sonogram of left breast 
mass demonstrated a complex mass with a solid nodular 
component. 
Figure 3B. 70-year-old man with intracystic papillary 
carcinoma. At presentation, transverse-axis sonogram of 
left breast mass demonstrated a complex mass with a solid 
nodular component. `
[5]. One study reported the incidence of gynecomastia 
to be 40-55%, determined at autopsy [12]. Several stud-
ies have shown the incidence of gynecomastia in male 
breast cancer patients to be consistent with or lower 
than baseline population levels [12,13], indicating no 
increased risk for breast cancer. However, the risk for 
gynecomastia and the risk for male breast cancer are 
both linked to a prolonged elevation of the estrogen-
to-androgen ratio and many consider gynecomastia a 
risk factor for developing male breast cancer given the 
high estrogen and low testosterone state associated with 
it [14]. In patients with longstanding gynecomastia, 
it is plausible that a correlation may exist between the 
duration of gynecomastia and the ultimate development 
of male breast cancer, but this relationship will likely 
remain unresolved given the small number of annual 
cases of male breast cancer and the broad prevalence of 
gynecomastia.
The presence of gynecomastia mammographically is 
considered diagnostic in explaining a retroareolar lump 
or tenderness, with additional work-up by ultrasound 
reported unnecessary, or even discouraged, according to 
a standard text [15]. Ultrasound has been reported to 
have utility in distinguishing between gynecomastia and 
carcinoma and should be utilized [16], but only if suspi-
cious features are present on physical exam or imaging. 
If there are suspicious findings, ultrasound of a male 
breast lump may be just as valuable as in the evaluation 
of a female breast lump [6,17]. While it is conceivable 
that a small breast cancer could be obscured by overly-
ing gynecomastia on mammography and visible on 
ultrasound, this problem has not been documented in 
the imaging literature. The high incidence of gyneco-
mastia, the low incidence of male breast cancer, and the 
absence of documented mammographically occult male 
breast cancer associated with gynecomastia, provide the 
rationale for not routinely performing breast ultrasound 
if gynecomastia is found mammographically.
Pathologically, intracystic carcinomas have been 
considered variants of ductal carcinoma in situ (DCIS). 
In recent years, the demonstration of myoepithelial cells 
by the immunohistochemical stains for smooth muscle 
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